NO983596D0 - Histamin H3-reseptorligander - Google Patents

Histamin H3-reseptorligander

Info

Publication number
NO983596D0
NO983596D0 NO983596A NO983596A NO983596D0 NO 983596 D0 NO983596 D0 NO 983596D0 NO 983596 A NO983596 A NO 983596A NO 983596 A NO983596 A NO 983596A NO 983596 D0 NO983596 D0 NO 983596D0
Authority
NO
Norway
Prior art keywords
alkyl
group
groups
pct
independently
Prior art date
Application number
NO983596A
Other languages
English (en)
Other versions
NO983596L (no
NO312762B1 (no
Inventor
Sarkis Barrett Kalindjian
Nigel Paul Shankley
Matthew John Tozer
Iain Mair Mcdonald
Michael John Pether
Elaine Anne Harper
Gillian Fairfull Watt
Tracey Cooke
Caroline Minli Rachel Low
Original Assignee
Black James Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602649.7A external-priority patent/GB9602649D0/en
Application filed by Black James Foundation filed Critical Black James Foundation
Publication of NO983596D0 publication Critical patent/NO983596D0/no
Publication of NO983596L publication Critical patent/NO983596L/no
Publication of NO312762B1 publication Critical patent/NO312762B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19983596A 1996-02-09 1998-08-05 Histamin H3-reseptorligander, deres fremstilling samt farmasöytiske preparater NO312762B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9602649.7A GB9602649D0 (en) 1996-02-09 1996-02-09 Histamine h3 receptor ligands
GBGB9624215.1A GB9624215D0 (en) 1996-02-09 1996-11-21 Histamine H3 receptor ligands
PCT/GB1997/000358 WO1997029092A1 (en) 1996-02-09 1997-02-10 Histamine h3 receptor ligands

Publications (3)

Publication Number Publication Date
NO983596D0 true NO983596D0 (no) 1998-08-05
NO983596L NO983596L (no) 1998-09-16
NO312762B1 NO312762B1 (no) 2002-07-01

Family

ID=26308645

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983596A NO312762B1 (no) 1996-02-09 1998-08-05 Histamin H3-reseptorligander, deres fremstilling samt farmasöytiske preparater

Country Status (14)

Country Link
US (1) US6080871A (no)
EP (1) EP0882023B1 (no)
JP (1) JP2000505428A (no)
CN (1) CN1215392A (no)
AT (1) ATE242219T1 (no)
AU (1) AU709611B2 (no)
CA (1) CA2244745A1 (no)
DE (1) DE69722592D1 (no)
HU (1) HUP9901190A3 (no)
NO (1) NO312762B1 (no)
NZ (1) NZ331272A (no)
PL (1) PL328369A1 (no)
RU (1) RU2182904C2 (no)
WO (1) WO1997029092A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000507584A (ja) * 1996-04-03 2000-06-20 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質転移酵素の阻害剤
US6407132B1 (en) * 1997-07-25 2002-06-18 James Black Foundation Limited Substituted imidazole derivatives and their use as histamine H3 receptor ligands
GB2344588B (en) * 1997-07-25 2001-11-14 Black James Foundation 1H-4(5)-substituted imidazole derivatives their preparation and their use as histamine H 3 receptor ligands
GB9715814D0 (en) * 1997-07-25 1997-10-01 Black James Foundation Histamine H3 receptor ligands
GB9803536D0 (en) 1998-02-19 1998-04-15 Black James Foundation Histamine H,receptor ligands
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
PL1735278T3 (pl) 2004-04-01 2010-06-30 Lilly Co Eli Związki receptora histaminowego H3, wytwarzanie i zastosowania terapeutyczne
EP1595881A1 (en) 2004-05-12 2005-11-16 Pfizer Limited Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
FR2870846B1 (fr) * 2004-05-25 2006-08-04 Sanofi Synthelabo Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
JP4942654B2 (ja) 2004-08-23 2012-05-30 イーライ リリー アンド カンパニー ヒスタミンｈ３受容体薬剤、製剤及び治療的使用
ES2310366T3 (es) * 2004-08-24 2009-01-01 Janssen Pharmaceutica Nv Nuevos derivados de heteroaril sulfonamida benzo-condensada utiles como agentes anticonvulsivos.
DE602005011988D1 (de) 2004-10-18 2009-02-05 Lilly Co Eli Histamin-h3-rezeptor inhibitoren, ihre herstellung und therapeutische anwendungen
EP1707203A1 (en) 2005-04-01 2006-10-04 Bioprojet Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands
CN101151244B (zh) 2005-04-01 2014-09-03 伊莱利利公司 组胺h3受体活性剂、制备和治疗用途
EP1717233A1 (en) * 2005-04-29 2006-11-02 Bioprojet Histamine H3-receptor ligands and their therapeutic application
EP1717235A3 (en) 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2372066A (en) * 1940-12-23 1945-03-20 Parke Davis & Co Biological product and process of obtaining same
US3497591A (en) * 1968-11-19 1970-02-24 Colgate Palmolive Co Dental preparations containing imidazole derivative
EP0082648A3 (en) * 1981-12-21 1984-09-26 Imperial Chemical Industries Plc Cephalosporin derivatives
DE3219113A1 (de) * 1982-05-21 1983-11-24 Bayer Ag, 5090 Leverkusen Verwendung von n-substituierten 2,3-diaminocarbonsaeuren in arzneimitteln und ihre herstellung
AU5410786A (en) * 1985-03-04 1986-09-11 Fujisawa Pharmaceutical Co., Ltd. Amino acid derivatives and processes for preparation thereof
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
AU7823894A (en) * 1993-08-27 1995-03-21 Vrije Universiteit New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor

Also Published As

Publication number Publication date
NZ331272A (en) 2000-01-28
PL328369A1 (en) 1999-01-18
RU2182904C2 (ru) 2002-05-27
HUP9901190A3 (en) 2002-05-28
US6080871A (en) 2000-06-27
EP0882023B1 (en) 2003-06-04
DE69722592D1 (de) 2003-07-10
JP2000505428A (ja) 2000-05-09
HUP9901190A2 (hu) 1999-09-28
AU1613697A (en) 1997-08-28
NO983596L (no) 1998-09-16
EP0882023A1 (en) 1998-12-09
CA2244745A1 (en) 1997-08-14
ATE242219T1 (de) 2003-06-15
CN1215392A (zh) 1999-04-28
AU709611B2 (en) 1999-09-02
NO312762B1 (no) 2002-07-01
WO1997029092A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
ATE242219T1 (de) Histamin h 3 rezeptorliganden
DK1309544T3 (da) Forbindelser, der virker som melanocortinreceptorligander
HK1035724A1 (en) Compounds as selective agonists at alpha 2B or 2B/2C adrenergic receptors.
IL110091A (en) POLYSUBSTITUTED IMIDAZO £4, 5-c| PYRIDIN-4-AMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK0665844T3 (da) Substituerede benzylaminoquinuclidinforbindelser som antagonister af substans P
GR861926B (en) Process for preparing heterocyclic compounds
GR861927B (en) Process for preparing heterocyclic compounds
IL100164A0 (en) Indan derivatives
HUP9900679A2 (hu) Simaizom sejtburjánzást gátló benzimidazolszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
GB2341861A (en) Substituted imidazole derivatives and their use as histamine H 3 receptor ligands
ES2170802T3 (es) Carboxamidas biciclicas como ligandos de los receptores 5-ht1a.
GB2341862A (en) Histamine H3 receptor ligands
ES514634A0 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
KR960007560A (ko) 신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
DK1068199T3 (da) N-Aryloxyethyl-indolyl-alkylaminer til behandling af depression
MX9709833A (es) Uso de benzimidazoles para la fabricacion de un medicamento para el tratamiento de leucemia.
TH18165EX (th) สารยับยั้งการเกิดคีโมแทกซิของอีโอซีโนฟีล

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2003